| scholarly article | Q13442814 |
| P2093 | author name string | T P Berg | |
| P2860 | cites work | Stimulation of chick hepatocyte fibronectin production by fibroblast-conditioned medium is due to interleukin 6 | Q72085515 |
| Evidence that virion-associated VP1 of avibirnaviruses contains viral RNA sequences | Q73523017 | ||
| The working mechanism of an immune complex vaccine that protects chickens against infectious bursal disease | Q77586828 | ||
| Restriction fragment length polymorphisms in the VP2 gene of infectious bursal disease viruses from outside the United States | Q77970555 | ||
| Acute infectious bursal disease in poultry: Isolation and characterisation of a highly virulent strain | Q81742063 | ||
| Infected and apoptotic cells in the IBDV-infected bursa of Fabricius, studied by double-labelling techniques | Q87367999 | ||
| Bursal lymphocyte proliferation in the presence of phorbol myristate acetate: Effect of IBDV strains on the proliferation response | Q87368004 | ||
| Infectious bursal disease in Western Australia | Q70152127 | ||
| Deduced amino acid sequences at the fusion protein cleavage site of Newcastle disease viruses showing variation in antigenicity and pathogenicity | Q70565095 | ||
| Production of interferon-gamma by chicken T cells | Q70974439 | ||
| Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids | Q29616817 | ||
| The chicken 9E3/CEF4 CXC chemokine is the avian orthologue of IL8 and maps to chicken chromosome 4 syntenic with genes flanking the mammalian chemokine cluster. | Q30322749 | ||
| Lysis of myelocytes in chickens infected with infectious bursal disease virus | Q30658110 | ||
| A non-canonical lon proteinase lacking the ATPase domain employs the ser-Lys catalytic dyad to exercise broad control over the life cycle of a double-stranded RNA virus | Q33885502 | ||
| Infectious bursal disease of poultry: antigenic structure of the virus and control | Q35237809 | ||
| The two segments of the infectious bursal disease virus genome are circularized by a 90,000-Da protein | Q36427116 | ||
| Chicken interferon gene: cloning, expression, and analysis | Q36675902 | ||
| Synthetic transcripts of double-stranded Birnavirus genome are infectious | Q37312745 | ||
| Production of antibodies against chicken interferon-gamma: demonstration of neutralizing activity and development of a quantitative ELISA. | Q38313381 | ||
| Biochemistry and immunology of infectious bursal disease virus | Q39245775 | ||
| Isolation and Assay of Rabies Serogroup Viruses in CER Cells | Q39432133 | ||
| Genomic structure of the large RNA segment of infectious bursal disease virus | Q40417232 | ||
| Replication of classical infectious bursal disease virus in the chicken embryo related cell line | Q40877426 | ||
| Interactions in vivo between the proteins of infectious bursal disease virus: capsid protein VP3 interacts with the RNA-dependent RNA polymerase, VP1. | Q40905143 | ||
| Efficient rescue of infectious bursal disease virus from cloned cDNA: evidence for involvement of the 3'-terminal sequence in genome replication | Q40911728 | ||
| Tissue culture infectivity of different strains of infectious bursal disease virus is determined by distinct amino acids in VP2. | Q40932462 | ||
| A chicken homolog of mammalian interleukin-1 beta: cDNA cloning and purification of active recombinant protein | Q40973117 | ||
| Some characteristics of a cellular receptor for virulent infectious bursal disease virus by using flow cytometry | Q40976002 | ||
| Alteration of chicken heterophil and macrophage functions by the infectious bursal disease virus | Q40999653 | ||
| Expression of ORF A1 of infectious bursal disease virus results in the formation of virus-like particles | Q41039790 | ||
| Infectious bursal disease virus polyprotein processing does not involve cellular proteases | Q41135761 | ||
| Nitric oxide inducing factor as a measure of antigen and mitogen-specific T cell responses in chickens | Q41192462 | ||
| Susceptibility of chicken monocytic cell lines to infectious bursal disease virus | Q41622803 | ||
| Heterogeneity of the antigenic site responsible for the induction of neutralizing antibodies in infectious bursal disease virus | Q41706492 | ||
| Chicken macrophage activation by interferon: do birds lack the molecular homologue of mammalian interferon-gamma? | Q41712908 | ||
| Chimeric infectious bursal disease virus-like particles expressed in insect cells and purified by immobilized metal affinity chromatography | Q42058392 | ||
| Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins | Q42068721 | ||
| A comparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a variable region in VP2. | Q42631793 | ||
| Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. | Q42680898 | ||
| Identification of a novel viral protein in infectious bursal disease virus-infected cells | Q42689283 | ||
| Sequential Changes in the Number of Surface Immunoglobulin-Bearing B Lymphocytes in Infectious Bursal Disease Virus-Infected Chickens | Q43933562 | ||
| Apoptosis induced by infectious bursal disease virus | Q43979534 | ||
| Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens. | Q44172730 | ||
| Acute infectious bursal disease in poultry | Q44320023 | ||
| Coding region of segment A sequence of a very virulent isolate of IBDV--comparison with isolates from different countries and virulence. | Q44386509 | ||
| Acute infectious bursal disease in poultry: protection afforded by maternally derived antibodies and interference with live vaccination | Q44460087 | ||
| Applications in in ovo technology | Q44693535 | ||
| Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States | Q44896267 | ||
| Changes in the field status of infectious bursal disease virus | Q44940249 | ||
| Transfer of antibodies elicited by baculovirus-derived VP2 of a very virulent bursal disease virus strain to progeny of commercial breeder chickens | Q45386977 | ||
| A double antibody sandwich ELISA for rapid diagnosis of virus infection and to measure the humoral response against infectious bursal disease on clinical material. | Q45394963 | ||
| Newcastle disease virus: Detection and characterization by PCR of recent German isolates differing in pathogenicity | Q45394971 | ||
| Inflammatory response of different chicken lines and B haplotypes to infection with infectious bursal disease virus | Q45394973 | ||
| Differentiation of virulent and non-virulent strains of Newcastle disease virus within 24 hours by polymerase chain reaction | Q45394997 | ||
| Comparison of the in situ changes in lymphoid cells during infection with infectious bursal disease virus in chickens of different ages | Q45394999 | ||
| Antigenic and sequence heterogeneity of infectious bursal disease virus strains isolated in Australia | Q45741564 | ||
| The VP2 variable region of African and German isolates of infectious bursal disease virus: comparison with very virulent, "classical" virulent, and attenuated tissue culture-adapted strains | Q45744678 | ||
| Generation of full-length cDNA of the two genomic dsRNA segments of infectious bursal disease virus | Q45744988 | ||
| Induction of protective immunity in chickens immunised with plasmid DNA encoding infectious bursal disease virus antigens | Q45745015 | ||
| Amplification and cloning of infectious bursal disease virus genomic RNA segments by long and accurate PCR. | Q45746940 | ||
| Proteolytic processing in infectious bursal disease virus: identification of the polyprotein cleavage sites by site-directed mutagenesis | Q45747190 | ||
| Sequence comparison of the VP2 variable region of infectious bursal disease virus isolates from Vietnam | Q45749288 | ||
| Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. | Q45749425 | ||
| Failure of viral protein 3 of infectious bursal disease virus produced in prokaryotic and eukaryotic expression systems to protect chickens against the disease. | Q45749863 | ||
| Sequence analysis of the VP2 hypervariable region of nine infectious bursal disease virus isolates from mainland China. | Q45752000 | ||
| Seroprevalence of infectious bursal disease virus in free-living wild birds in Japan | Q45752320 | ||
| Molecular characterization of seven Chinese isolates of infectious bursal disease virus: classical, very virulent, and variant strains. | Q45755245 | ||
| Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease | Q45755262 | ||
| Enhanced expression of cytokine genes in spleen macrophages during acute infection with infectious bursal disease virus in chickens | Q45755761 | ||
| In-situ apoptosis in chickens infected with infectious bursal disease virus | Q45757485 | ||
| Limited antigenic variation among recent infectious bursal disease virus isolates from France | Q45758847 | ||
| Sequence and phylogenetic analyses of highly virulent infectious bursal disease virus | Q45761003 | ||
| Poultry virus infection in Antarctic penguins | Q45762987 | ||
| Modified activity of a VP2-located neutralizing epitope on various vaccine, pathogenic and hypervirulent strains of infectious bursal disease virus | Q45763540 | ||
| Identification of sequence changes responsible for the attenuation of highly virulent infectious bursal disease virus | Q45768250 | ||
| Coding sequences of both genome segments of a European 'very virulent' infectious bursal disease virus | Q45769438 | ||
| Comparison of virus replication efficiency in lymphoid tissues among three infectious bursal disease virus strains. | Q45769526 | ||
| Susceptibility of chicken lymphoid cells to infectious bursal disease virus does not correlate with the presence of specific binding sites | Q45769921 | ||
| Sequence comparisons of a highly virulent infectious bursal disease virus prevalent in Japan. | Q45774750 | ||
| Genetic differences in susceptibility of chicken lines to infection with infectious bursal disease virus | Q45775503 | ||
| Molecular basis of antigenic variation in infectious bursal disease virus | Q45778525 | ||
| VP2 sequences of recent European 'very virulent' isolates of infectious bursal disease virus are closely related to each other but are distinct from those of 'classical' strains | Q45779330 | ||
| Association between pathogenicity of infectious bursal disease virus and viral antigen distribution detected by immunohistochemistry. | Q45785043 | ||
| Pathogenesis of Highly Virulent Infectious Bursal Disease Virus Infection in Intact and Bursectomized Chickens | Q45786571 | ||
| The genetic basis for the antigenicity of the VP2 protein of the infectious bursal disease virus | Q45786821 | ||
| Replication of infectious bursal disease virus in continuous cell lines. | Q45834387 | ||
| Susceptibility of chicken blood lymphoblasts and monocytes to infectious bursal disease virus (IBDV). | Q45834842 | ||
| The characterization and molecular cloning of the double-stranded RNA genome of an Australian strain of infectious bursal disease virus | Q45837878 | ||
| Properties of RNA polymerase activity associated with infectious bursal disease virus and characterization of its reaction products | Q45842451 | ||
| A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens | Q45845818 | ||
| Comparative pathogenesis of serotype 1 and variant serotype 1 isolates of infectious bursal disease virus and their effect on humoral and cellular immune competence of specific-pathogen-free chickens. | Q45846200 | ||
| Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus | Q45847698 | ||
| Passive protection against infectious bursal disease virus by viral VP2 expressed in yeast | Q45853776 | ||
| A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. | Q45861659 | ||
| Immune dysfunction following infection with chicken anemia agent and infectious bursal disease virus. II. Alterations of in vitro lymphoproliferation and in vivo immune responses | Q45876313 | ||
| Immune dysfunction following infection with chicken anemia agent and infectious bursal disease virus. I. Kinetic alterations of avian lymphocyte subpopulations | Q45876316 | ||
| Isolation of Virulent Infectious Bursal Disease Virus from Field Outbreaks with High Mortality in Japan | Q45879990 | ||
| Acute infectious bursal disease in poultry: Immunological and molecular basis of antigenicity of a highly virulent strain | Q47859340 | ||
| Sequence analysis of Australian infectious bursal disease viruses | Q47973292 | ||
| Critical amino acid changes in VP2 variable domain are associated with typical and atypical antigenicity in very virulent infectious bursal disease viruses | Q48022473 | ||
| Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus. | Q54759872 | ||
| Molecular characterization of Brazilian avian pneumovirus isolates using reverse transcription-polymerase chain reaction, restriction endonuclease analysis and sequencing of a G gene fragment | Q56797426 | ||
| Antigenic and genetic relationships between European very virulent infectious bursal disease viruses and an early West African isolate | Q57984490 | ||
| Monokine‐like activities released from a chicken macrophage line | Q58300606 | ||
| Occurrence of acute infectious bursal disease with high mortality in Japan and pathogenicity of field isolates in specific-pathogen-free chickens | Q67505388 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 175-194 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Avian Pathology | Q15763138 |
| P1476 | title | Acute infectious bursal disease in poultry: a review | |
| P478 | volume | 29 |
| Q39297750 | A 5-year study of the incidence and economic impact of variant infectious bursal disease viruses on broiler production in Saskatchewan, Canada |
| Q39278091 | A model for the transfer of passive immunity against Newcastle disease and avian influenza in specific pathogen free chickens |
| Q102056989 | A reassortment vaccine candidate of the novel variant infectious bursal disease virus |
| Q47095441 | Adaptation and Molecular Characterization of Two Malaysian Very Virulent Infectious Bursal Disease Virus Isolates Adapted in BGM-70 Cell Line. |
| Q42275692 | Adjuvant effects of interleukin-18 in DNA vaccination against infectious bursal disease virus in chickens |
| Q39028830 | Advances in vaccine research against economically important viral diseases of food animals: Infectious bursal disease virus |
| Q57106012 | Amino acid changes in the variable region of VP2 in three infectious bursal disease viruses with different virulence, originating from a common ancestor |
| Q45418898 | An ELISA for detection of infectious bursal disease virus and differentiation of very virulent strains based on single chain recombinant chicken antibodies |
| Q42224339 | An influenza A virus hemagglutinin (HA) epitope inserted in and expressed from several loci of the infectious bursal disease virus genome induces HA-specific antibodies |
| Q59360787 | Antigenicity characterization of four representative natural reassortment IBDVs isolated from commercial three-yellow chickens from Southern China reveals different subtypes co-prevalent in the field |
| Q38334265 | Assessment of genetic, antigenic and pathotypic criteria for the characterization of IBDV strains |
| Q42235180 | Assessment of impact of a novel infectious bursal disease (IBD) vaccination programme in breeders on IBD humoral antibody levels through the laying period. |
| Q45697546 | Base usage and dinucleotide frequency of infectious bursal disease virus |
| Q36607122 | Both genome segments contribute to the pathogenicity of very virulent infectious bursal disease virus |
| Q39604999 | C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly |
| Q45413245 | Changes in VP3 and VP5 genes during the attenuation of the very virulent infectious bursal disease virus strain Gx isolated in China |
| Q42252244 | Characterization of field and vaccine infectious bursal disease viruses from Nigeria revealing possible virulence and regional markers in the VP2 minor hydrophilic peaks |
| Q45730179 | Characterization of the antigenic, immunogenic, and pathogenic variation of infectious bursal disease virus due to propagation in different host systems (bursa, embryo, and cell culture). III. Pathogenicity |
| Q89845805 | Characterization of the highly immunogenic VP2 protrusion domain as a diagnostic antigen for members of Birnaviridae family |
| Q40482910 | Characterization of variant infectious bursal disease virus from a broiler farm in Japan using immunized sentinel chickens |
| Q45414337 | Chicken recombinant antibodies against infectious bursal disease virus are able to form antibody-virus immune complex |
| Q38616431 | Classification of infectious bursal disease virus into genogroups |
| Q36610601 | Cloning and Expression of Gumboro VP2 Antigen in Aspergillus niger |
| Q42264749 | Codon optimization and woodchuck hepatitis virus posttranscriptional regulatory element enhance the immune responses of DNA vaccines against infectious bursal disease virus in chickens |
| Q64098869 | Comparative Evaluation of HVT-IBD Vector, Immune Complex, and Live IBD Vaccines against vvIBDV in Commercial Broiler Chickens with High Maternally Derived Antibodies |
| Q40788875 | Comparison of RNA and cDNA transfection methods for rescue of infectious bursal disease virus |
| Q59813756 | Complete Genome Sequence of a Novel Very Virulent Strain of Infectious Bursal Disease Virus Circulating in Russia |
| Q34364428 | Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens |
| Q84995971 | Conjugated linoleic acids alleviate the immunosuppression of peripheral blood T lymphocytes in broiler chickens exposed to cyclosporin A |
| Q38799241 | Continuous cell lines from the Muscovy duck as potential replacement for primary cells in the production of avian vaccines |
| Q38003693 | Current status of vaccines against infectious bursal disease |
| Q41151315 | Cyclophilin A Interacts with Viral VP4 and Inhibits the Replication of Infectious Bursal Disease Virus |
| Q45513400 | DNA immunization against very virulent infectious bursal disease virus with VP2-4-3 gene and chicken IL-6 gene |
| Q45399855 | DNA vaccination with VP2 gene of very virulent infectious bursal disease virus (vvIBDV) delivered by transgenic E. coli DH5alpha given orally confers protective immune responses in chickens |
| Q74841448 | DNA-mediated vaccination against infectious bursal disease in chickens |
| Q45732384 | Detection of infectious bursal disease virus in different lymphoid organs by single-step reverse transcription polymerase chain reaction and microplate hybridization assay |
| Q38787831 | Detection of vvIBDV in vaccinated SPF chickens |
| Q43768093 | Development of a tailored vaccine against challenge with very virulent infectious bursal disease virus of chickens using reverse genetics |
| Q45394929 | Development of an enzyme-linked immunosorbent assay for detecting infectious bursal disease virus (IBDV) infection based on the VP3 structural protein |
| Q42219540 | Dietary L-arginine modulates immunosuppression in broilers inoculated with an intermediate strain of infectious bursa disease virus |
| Q82222015 | Differences in genetic background influence the induction of innate and acquired immune responses in chickens depending on the virulence of the infecting infectious bursal disease virus (IBDV) strain |
| Q27311642 | Different domains of the RNA polymerase of infectious bursal disease virus contribute to virulence |
| Q35605117 | Differential modulation of immune response and cytokine profiles in the bursae and spleen of chickens infected with very virulent infectious bursal disease virus |
| Q45393678 | Direct detection of infectious bursal disease virus from clinical samples by in situ reverse transcriptase-linked polymerase chain reaction |
| Q45608970 | Dogs as potential carriers of infectious bursal disease virus |
| Q42267004 | Dual infections with low virulent chicken infectious anaemia virus (lvCIAV) and intermediate infectious bursal disease virus (iIBDV) in young chicks increase lvCIAV in thymus and bursa while decreasing lymphocyte disorders induced by iIBDV. |
| Q44320391 | Early stages of infectious bursal disease virus infection in chickens detected by in situ reverse transcriptase-polymerase chain reaction |
| Q36554577 | Economically important non-oncogenic immunosuppressive viral diseases of chicken--current status |
| Q45325945 | Effect of maternally derived antibody on sequential infection with highly virulent bursal disease virus in newly hatched broilers |
| Q38880447 | Effective multiple oral administration of reverse genetics engineered infectious bursal disease virus in mice in the presence of neutralizing antibodies |
| Q40872450 | Effects of temperature, relative humidity, absolute humidity, and evaporation potential on survival of airborne Gumboro vaccine virus |
| Q45386928 | Efficacy of inactivated infectious bursal disease (IBD) vaccines: comparison of serology with protection of progeny chickens against IBD virus strains of varying virulence |
| Q45499396 | Enhanced immunopathology induced by very virulent infectious bursal disease virus |
| Q35623346 | Evaluation of a Phylogenetic Marker Based on Genomic Segment B of Infectious Bursal Disease Virus: Facilitating a Feasible Incorporation of this Segment to the Molecular Epidemiology Studies for this Viral Agent |
| Q45418887 | Evaluation of the enzyme-linked immunosorbent assay for the detection of antibodies against infectious bursal disease virus (IBDV) and the estimation of the optimal age for IBDV vaccination in broilers |
| Q40629032 | Evidence of genetic drift and reassortment in infectious bursal disease virus and emergence of outbreaks in poultry farms in India |
| Q98237865 | Ex vivo rescue of recombinant very virulent IBDV using a RNA polymerase II driven system and primary chicken bursal cells |
| Q52655443 | Exacerbated apoptosis of cells infected with infectious bursal disease virus (IBDV) upon exposure to Interferon alpha (IFN-α). |
| Q38996020 | Extensive antigenic changes in an atypical isolate of very virulent infectious bursal disease virus and experimental clinical control of this virus with an antigenically classical live vaccine |
| Q42199672 | Function of duck RIG-I in induction of antiviral response against IBDV and avian influenza virus on chicken cells |
| Q45355710 | Fusion protein strategy to increase expression and solubility of hypervariable region of VP2 protein of infectious bursal disease virus in Escherichia coli |
| Q44336129 | Generation of serotype 1/serotype 2 reassortant viruses of the infectious bursal disease virus and their investigation in vitro and in vivo |
| Q48079609 | Genetic characteristics of infectious bursal disease viruses from four continents |
| Q41280404 | Genetic characterization of South American infectious bursal disease virus reveals the existence of a distinct worldwide-spread genetic lineage |
| Q45325943 | Genome sequence analysis of a distinctive Italian infectious bursal disease virus. |
| Q92415951 | Genotype-associated differences in bursal recovery after infectious bursal disease virus (IBDV) inoculation |
| Q45362942 | Identification and pathogenicity of a natural reassortant between a very virulent serotype 1 infectious bursal disease virus (IBDV) and a serotype 2 IBDV. |
| Q57093132 | Identification of Infectious Bursal Disease Virus with Atypical VP2 Amino Acid Profile in Latvia |
| Q95660451 | Identification of Reference Genes in Chicken Intraepithelial Lymphocyte Natural Killer Cells Infected with Very-virulent Infectious Bursal Disease Virus |
| Q42235399 | Immune response elicited by the oral administration of an intermediate strain of IBDV in chickens |
| Q59354352 | Immunogenicity and protective efficacy of orally administered recombinant Lactobacillus plantarum expressing VP2 protein against IBDV in chicken |
| Q41854986 | Immunogenicity of formaldehyde and binary ethylenimine inactivated infectious bursal disease virus in broiler chicks |
| Q37678299 | Immunomodulatory and Anti-IBDV Activities of the Polysaccharide AEX from Coccomyxa gloeobotrydiformis. |
| Q45414329 | Impact of heterophil granulocyte depletion caused by 5-fluorouracil on infectious bursal disease virus infection in specific pathogen free chickens |
| Q34044564 | Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens |
| Q41034877 | In vitro characterization of chicken bone marrow-derived dendritic cells following infection with very virulent infectious bursal disease virus. |
| Q40225842 | Induction of apoptosis in the bursa of Fabricius by vaccination against Gumboro disease |
| Q42259895 | Induction of non-specific suppression in chicks by specific combination of maternal antibody and related antigen |
| Q45359054 | Induction of protective immunity in chickens immunized with plant-made chimeric Bamboo mosaic virus particles expressing very virulent Infectious bursal disease virus antigen |
| Q45466154 | Infection and activation of bursal macrophages by virulent infectious bursal disease virus |
| Q45710776 | Infectious Bursal Disease Virus and Proventriculitis in Broiler Chickens |
| Q42027410 | Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site |
| Q39514165 | Infectious bursal disease virus activates the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway by interaction of VP5 protein with the p85α subunit of PI3K. |
| Q93189780 | Infectious bursal disease virus in chickens: prevalence, impact, and management strategies |
| Q39463839 | Infectious bursal disease virus-induced activation of JNK signaling pathway is required for virus replication and correlates with virus-induced apoptosis |
| Q40157657 | Infectious bursal disease: outbreak investigation, molecular characterization, and vaccine immunogenicity trial in Ethiopia |
| Q37382455 | Innovation and discovery: the application of nucleic acid-based technology to avian virus detection and characterization |
| Q36979479 | Isolation of Infectious Bursal Disease Virus Using Indigenous Chicken Embryos in Kenya |
| Q42017341 | L-Arginine stimulates intestinal intraepithelial lymphocyte functions and immune response in chickens orally immunized with live intermediate plus strain of infectious bursal disease vaccine |
| Q46707922 | L-arginine stimulates immune response in chickens immunized with intermediate plus strain of infectious bursal disease vaccine |
| Q45185648 | Mast cell mediated inflammatory response in chickens after infection with very virulent infectious bursal disease virus |
| Q37664472 | Model or meal? Farm animal populations as models for infectious diseases of humans. |
| Q37661125 | Modelling the evolution of HIV-1 virulence in response to imperfect therapy and prophylaxis |
| Q40600195 | Modifications of the 3'-UTR stem-loop of infectious bursal disease virus are allowed without influencing replication or virulence |
| Q44415746 | Molecular Characterization of Infectious Bursal Disease Virus from Commercial Poultry in the United States and Latin America |
| Q42910729 | Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus |
| Q51739663 | Molecular characteristic of VP2 gene of infectious bursal disease viruses isolated from a farm in two decades. |
| Q37584756 | Molecular characterization of field infectious bursal disease virus isolates from Nigeria |
| Q40886444 | Molecular characterization of infectious bursal disease virus (IBDV) isolated in Argentina indicates a regional lineage |
| Q41935607 | Molecular characterization of very virulent infectious bursal disease virus strains circulating in Egypt from 2003 to 2014. |
| Q39949793 | Molecular epizootiology of infectious bursal disease (IBD) in Korea |
| Q91783153 | Naturally occurring cell-adapted classic strain of infectious bursal disease virus |
| Q92420719 | Novel variants of infectious bursal disease virus can severely damage the bursa of fabricius of immunized chickens |
| Q45403033 | Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens |
| Q40551011 | Outbreaks of Virulent Infectious Bursal Disease in Flocks of Battery Cage Brooding System of Commercial Chickens |
| Q42002192 | Overexpression of recombinant infectious bursal disease virus (IBDV) capsid protein VP2 in the middle silk gland of transgenic silkworm |
| Q38402961 | Pair-epitopes vaccination: enabling offspring vaccination in the presence of maternal antibodies |
| Q41976984 | Partial VP1 sequencing of Brazilian infectious bursal disease virus strains |
| Q38633565 | Passive immunization with hyperimmune egg-yolk IgY as prophylaxis and therapy for poultry diseases--A review |
| Q42267399 | Pathogenicity associated with coinfection with very virulent infectious bursal disease and Infectious bursal disease virus strains endemic in the United States |
| Q44253352 | Pathogenicity of SspI-positive infectious bursal disease virus and molecular characterization of the VP2 hypervariable region |
| Q40494729 | Pathogenicity, tissue distribution, shedding and environmental detection of two strains of IBDV following infection of chickens at 0 and 14 days of age. |
| Q43119879 | Phylogenetic analysis reveals a correlation between the expansion of very virulent infectious bursal disease virus and reassortment of its genome segment B. |
| Q43520672 | Phylogeographic distribution of very virulent infectious bursal disease virus isolates in the Iberian Peninsula. |
| Q53525047 | Pivotal role of ChIFNgamma in the pathogenesis and immunosuppression of infectious bursal disease. |
| Q57020823 | Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs |
| Q36485644 | Potential drivers of virulence evolution in aquaculture |
| Q93011930 | Predicting vaccine effectiveness in livestock populations: A theoretical framework applied to PRRS virus infections in pigs |
| Q39945745 | Preparation and evaluation of an experimental iscom-based infectious bursal disease vaccine |
| Q40719678 | Prophylactic potential of resiquimod against very virulent infectious bursal disease virus (vvIBDV) challenge in the chicken. |
| Q45704172 | Protection from infectious bursal disease virus (IBDV)-induced immunosuppression by immunization with a fowlpox recombinant containing IBDV-VP2. |
| Q40240899 | Protective efficacy of a novel recombinant Marek's disease virus vector vaccine against infectious bursal disease in chickens with or without maternal antibodies |
| Q35077976 | Protective oral vaccination against infectious bursal disease virus using the major viral antigenic protein VP2 produced in Pichia pastoris |
| Q45357423 | Proteome dynamics in primary target organ of infectious bursal disease virus |
| Q45652782 | RT-PCR amplification and BmrI restriction digestion for the rapid detection of exotic strains of infectious bursal disease virus |
| Q59356000 | Rapid detection of infectious bursal disease by loop-mediated isothermal amplification for field analysis |
| Q37508539 | Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens |
| Q40811637 | Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development |
| Q44213121 | Reduced mucosal injury of SPF chickens by mast cell stabilization after infection with very virulent infectious bursal disease virus |
| Q35592766 | Research on infectious bursal disease--the past, the present and the future |
| Q45729092 | Restriction fragment length polymorphism analysis of the VP2 gene of Australian strains of infectious bursal disease virus |
| Q45609146 | Reversion of molecularly engineered, partially attenuated, very virulent infectious bursal disease virus during infection of commercial chickens |
| Q55128431 | Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. |
| Q40705003 | Role of naturally occurring genome segment reassortment in the pathogenicity of IBDV field isolates in Three-Yellow chickens |
| Q83276086 | Sequence analysis of the VP2 gene hypervariable region of infectious bursal disease viruses from India |
| Q91447798 | Serological study reveal different antigenic IBDV strains prevalent in southern China during the years 2000-2017 and also the antigenic differences between the field strains and the commonly used vaccine strains |
| Q41694562 | Seroprevalence of infectious bursal disease virus in local chickens in Udu Local Government Area of Delta State, South East Nigeria. |
| Q42047559 | Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines. |
| Q39053814 | Susceptibility of vaccinated and unvaccinated Egyptian chickens to very virulent infectious bursal disease virus |
| Q38721408 | Transcriptional profiles in bursal B-lymphoid DT40 cells infected with very virulent infectious bursal disease virus |
| Q101038726 | Transcriptome analysis of chicken intraepithelial lymphocyte natural killer cells infected with very virulent infectious bursal disease virus |
| Q40413599 | Turkey herpesvirus with an insertion in the UL3-4 region displays an appropriate balance between growth activity and antibody-eliciting capacity and is suitable for the establishment of a recombinant vaccine |
| Q39053791 | Very virulent infectious bursal disease virus in Egypt: epidemiology, isolation and immunogenicity of classic vaccine |
| Q62128249 | Virus-like particle-based vaccines for animal viral infections |
| Q38019283 | Virus-like particles: the new frontier of vaccines for animal viral infections. |
| Q60301818 | Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance |
Search more.